E7080
Phase 1Completed 0 watching 0 views this week💤 Quiet
33
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Metastatic Melanoma
Conditions
Metastatic Melanoma
Trial Timeline
Jul 1, 2005 → May 1, 2015
NCT ID
NCT00121680About E7080
E7080 is a phase 1 stage product being developed by Eisai for Metastatic Melanoma. The current trial status is completed. This product is registered under clinical trial identifier NCT00121680. Target conditions include Metastatic Melanoma.
Hype Score Breakdown
Clinical
10
Activity
5
Company
10
Novelty
3
Community
2
Clinical Trials (3)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01268293 | Phase 1 | Completed |
| NCT00280397 | Phase 1 | Completed |
| NCT00121680 | Phase 1 | Completed |
Competing Products
20 competing products in Metastatic Melanoma